Medical device recalls Moderate risk

Beckman Coulter Inc. recalls Beckman Coulter, Lipase Assay, Catalog No. OSR6X30

Recall date
December 15, 2014
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-1023-2015
FDA classification
Class II
Brand / firm
Beckman Coulter Inc.
Sold / distributed
Nationwide in US and Puerto Rico. World Wide: Albania, Algeria, Australia, Austria, Bahrain, Bangladesh, Belarus, Belgium, Bolivia, Bosnia-Herzegovina, Botswana, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Cyrus, Czech Republic, Denmark, Ecuador, Egypt, El Salvador, Eritr…

Why it was recalled

N-Acetyl Cysteine (NAC), when administered in therapeutic concentrations for the treatment of acetaminophen overdose, interferes with the assays for these analytes: Cholesterol OSR6X16, Uric Acid OSR6X98, Lactate OSR6X93, and Lipase OSR6X30. NAC interference may lead to falsely low results.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Beckman Coulter, Lipase Assay, Catalog No. OSR6X30

Get recall alerts

Free email alert whenever Beckman Coulter Inc. has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Beckman Coulter Inc.